Sofosbuvir, velpatasvir and voxilaprevir combination therapy for treating patients with hepatitis C virus infection. [electronic resource]
Producer: 20180730Description: 255-268 p. digitalISSN:- 1699-3993
- Aminoisobutyric Acids
- Antiviral Agents -- adverse effects
- Carbamates -- adverse effects
- Cyclopropanes
- Drug Combinations
- Hepacivirus -- drug effects
- Hepatitis C -- diagnosis
- Heterocyclic Compounds, 4 or More Rings -- adverse effects
- Humans
- Lactams, Macrocyclic
- Leucine -- analogs & derivatives
- Macrocyclic Compounds -- adverse effects
- Proline -- analogs & derivatives
- Quinoxalines
- Sofosbuvir -- adverse effects
- Sulfonamides -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.